The activation peptide of coagulation factor XIII is vital for its expression and stability

Journal of Thrombosis and Haemostasis

Volumn 13, Issue 8, 2015, Pages 1449-1458

  Handrkova, H ^a,b   Schroeder, V ^a,b   Kohler, H P ^a,b,c  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c Spital Netz Bern   (Switzerland)

Author keywords

Dimerization; Factor XIII; Factor XIII activation peptide; Plasma transglutaminase; Protein stability

Indexed keywords

BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 13 ACTIVATION PEPTIDE; CATRIDECACOG; DIMER; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; THROMBIN; UNCLASSIFIED DRUG; BLOOD CLOTTING FACTOR 13A; FACTOR XIII ACTIVATION PEPTIDE; PEPTIDE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CHINESE HAMSTER; COMPUTER MODEL; CONTROLLED STUDY; CRUSTACEA; DIMERIZATION; ENZYME ACTIVATION; FEMALE; HUMAN; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; THERMOSTABILITY; WILD TYPE; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; CHO CELL LINE; CRICETULUS; ENZYME STABILITY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOLECULAR GENETICS; MUTATION; PROTEIN DENATURATION; PROTEIN MOTIF; PROTEIN MULTIMERIZATION; TEMPERATURE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; CHO CELLS; CRICETULUS; ENZYME ACTIVATION; ENZYME STABILITY; FACTOR XIII; FACTOR XIIIA; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; PEPTIDES; PROTEIN DENATURATION; PROTEIN MULTIMERIZATION; TEMPERATURE; TRANSFECTION; TRANSGLUTAMINASES;

EID: 84937977364     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.13035     Document Type: Article

References (38)

1. Muszbek L, Bereczky Z, Bagoly Z, Komaromi I, Katona E. Factor XIII: a coagulation factor with multiple plasmatic and cellular functions. Physiol Rev 2011; 91: 931-72.
2. Schroeder V, Kohler HP. New developments in the area of factor XIII. J Thromb Haemost 2013; 11: 234-44.
3. Richardson VR, Cordell P, Standeven KF, Carter AM. Substrates of factor XIII-A: roles in thrombosis and wound healing. Clin Sci (Lond) 2013; 124: 123-37.
4. Hornyak TJ, Shafer JA. Role of calcium ion in the generation of factor XIII activity. Biochemistry 1991; 30: 6175-82.
5. Yee VC, Pedersen LC, Bishop PD, Stenkamp RE, Teller DC. Structural evidence that the activation peptide is not released upon thrombin cleavage of factor XIII. Thromb Res 1995; 78: 389-97.
6. Ortner E, Schroeder V, Walser R, Zerbe O, Kohler HP. Sensitive and selective detection of free FXIII activation peptide: a potential marker of acute thrombotic events. Blood 2010; 115: 5089-96.
7. Kristiansen GK, Andersen MD. Reversible activation of cellular factor XIII by calcium. J Biol Chem 2011; 286: 9833-9.
8. Polgar J, Hidasi V, Muszbek L. Non-proteolytic activation of cellular protransglutaminase (placenta macrophage factor XIII). Biochem J 1990; 267: 557-60.
9. Komaromi I, Bagoly Z, Muszbek L. Factor XIII: novel structural and functional aspects. J Thromb Haemost 2011; 9: 9-20.
10. Weiss MS, Metzner HJ, Hilgenfeld R. Two non-proline cis peptide bonds may be important for factor XIII function. FEBS Lett 1998; 423: 291-6.
11. Sadasivan C, Yee VC. Interaction of the factor XIII activation peptide with alpha-thrombin. Crystal structure of its enzyme-substrate analog complex. J Biol Chem 2000; 275: 36942-8.
12. Balogh I, Szoke G, Karpati L, Wartiovaara U, Katona E, Komaromi I, Haramura G, Pfliegler G, Mikkola H, Muszbek L. Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia. Blood 2000; 96: 2479-86.
13. Kohler HP, Ariens RA, Whitaker P, Grant PJ. A common coding polymorphism in the FXIII A-subunit gene (FXIIIVal34Leu) affects cross-linking activity. Thromb Haemost 1998; 80: 704.
14. Ariens RA, Philippou H, Nagaswami C, Weisel JW, Lane DA, Grant PJ. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood 2000; 96: 988-95.
15. Schroeder V, Chatterjee T, Kohler HP. Influence of blood coagulation factor XIII and FXIII Val34Leu on plasma clot formation measured by thrombelastography. Thromb Res 2001; 104: 467-74.
16. Johansson L, Karpf DM, Hansen L, Pelzer H, Persson E. Activation peptides prolong the murine plasma half-life of human factor VII. Blood 2011; 117: 3445-52.
17. Ariens RA, Kohler HP, Mansfield MW, Grant PJ. Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals. Relation to sex, age, smoking, and hypertension. Arterioscler Thromb Vasc Biol 1999; 19: 2012-16.
18. Tsunasawa S, Stewart JW, Sherman F. Amino-terminal processing of mutant forms of yeast iso-1-cytochrome c. The specificities of methionine aminopeptidase and acetyltransferase. J Biol Chem 1985; 260: 5382-91.
19. Sherman F, Stewart JW, Tsunasawa S. Methionine or not methionine at the beginning of a protein. BioEssays 1985; 3: 27-31.
20. Polevoda B, Sherman F. N-terminal acetyltransferases and sequence requirements for N-terminal acetylation of eukaryotic proteins. J Mol Biol 2003; 325: 595-622.
21. Bachmair A, Finley D, Varshavsky A. In vivo half-life of a protein is a function of its amino-terminal residue. Science 1986; 234: 179-86.
22. Varshavsky A. The N-end rule pathway and regulation by proteolysis. Protein Sci 2011; 20: 1298-345.
23. Krissinel E. Macromolecular complexes in crystals and solutions. Acta Crystallogr D Biol Crystallogr 2011; 67: 376-85.
24. Dong A, Kendrick B, Kreilgard L, Matsuura J, Manning MC, Carpenter JF. Spectroscopic study of secondary structure and thermal denaturation of recombinant human factor XIII in aqueous solution. Arch Biochem Biophys 1997; 347: 213-20.
25. Kurochkin IV, Procyk R, Bishop PD, Yee VC, Teller DC, Ingham KC, Medved LV. Domain structure, stability and domain-domain interactions in recombinant factor XIII. J Mol Biol 1995; 248: 414-30.
26. Takahashi N, Takahashi Y, Putnam FW. Primary structure of blood coagulation factor XIIIa (fibrinoligase, transglutaminase) from human placenta. Proc Natl Acad Sci USA 1986; 83: 8019-23.
27. Cariello L, Ristoratore F, Zanetti L. A new transglutaminase-like from the ascidian Ciona intestinalis. FEBS Lett 1997; 408: 171-6.
28. Yeh MS, Kao LR, Huang CJ, Tsai IH. Biochemical characterization and cloning of transglutaminases responsible for hemolymph clotting in Penaeus monodon and Marsupenaeus japonicus. Biochim Biophys Acta 2006; 1764: 1167-78.
29. Lin X, Soderhall K, Soderhall I. Transglutaminase activity in the hematopoietic tissue of a crustacean, Pacifastacus leniusculus, importance in hemocyte homeostasis. BMC Immunol 2008; 9: 58.
30. Meinnel T, Peynot P, Giglione C. Processed N-termini of mature proteins in higher eukaryotes and their major contribution to dynamic proteomics. Biochimie 2005; 87: 701-12.
31. Yurimoto H, Yamane M, Kikuchi Y, Matsui H, Kato N, Sakai Y. The pro-peptide of Streptomyces mobaraensis transglutaminase functions in cis and in trans to mediate efficient secretion of active enzyme from methylotrophic yeasts. Biosci Biotechnol Biochem 2004; 68: 2058-69.
32. Shanbhag S, Shetty S, Ghosh K. Mutations in coagulation factor XIII subunit A in severe factor XIII deficiency patients: five novel mutations detected. Haemophilia 2011; 17: e843-5.
33. Mikkola H, Syrjälä M, Rasi V, Vahtera E, Hämäläinen E, Peltonen L, Palotie A. Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levels. Blood 1994; 84: 517-25.
34. Mikkola H, Yee VC, Syrjälä M, Seitz R, Egbring R, Petrini P, Ljung R, Ingerslev J, Teller DC, Peltonen L, Palotie A. Four novel mutations in deficiency of coagulation factor XIII: consequences to expression and structure of the A-subunit. Blood 1996; 87: 141-51.
35. Handrkova H, Borhany M, Schroeder V, Fatima N, Hussain A, Shamsi T, Kohler HP. Identification of two novel missense mutations causing severe factor XIII deficiency. Haemophilia 2015; 21: e253-6.
36. Kanchan K, Ergulen E, Kiraly R, Simon-Vecsei Z, Fuxreiter M, Fesus L. Identification of a specific one amino acid change in recombinant human transglutaminase 2 that regulates its activity and calcium sensitivity. Biochem J 2013; 455: 261-72.
37. Bergamini CM, Dean M, Matteucci G, Hanau S, Tanfani F, Ferrari C, Boggian M, Scatturin A. Conformational stability of human erythrocyte transglutaminase. Patterns of thermal unfolding at acid and alkaline pH. Eur J Biochem 1999; 266: 575-82.
38. Wu W, Sinha D, Shikov S, Yip CK, Walz T, Billings PC, Lear JD, Walsh PN. Factor XI homodimer structure is essential for normal proteolytic activation by factor XIIa, thrombin, and factor XIa. J Biol Chem 2008; 283: 18655-64.